LK-3
General Information
DRACP ID DRACP04064
Peptide Name LK-3
Sequence LKKLCKLLKKLCKLAG,LKKLCKLLKKLCKLAG
Sequence Length 33
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antiviral
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Acetylation,Acetylation
C-terminal Modification Amidation,Amidation
Other Modification None
Chiral Mix
Physicochemical Information
Formula C166H312N44O32S4
Absent amino acids DEFHIMNPQRSTVWY
Common amino acids KL
Mass 413584
Pl 10.95
Basic residues 12
Acidic residues 0
Hydrophobic residues 14
Net charge 12
Boman Index 306
Hydrophobicity 35.15
Aliphatic Index 147.88
Half Life
/
Extinction Coefficient cystines 250
Absorbance 280nm 7.81
Polar residues 6
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 25056130
Title Cell-penetrating, dimeric δΌͺ-helical peptides: nanomolar inhibitors of HIV-1 transcription
Doi Not available
Year 2014
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 16542